IMPACT OF RENAL IMPAIRMENT ON PLATELET REACTIVITY AND CLINICAL OUTCOMES DURING CHRONIC DUAL ANTIPLATELET THERAPY FOLLOWING CORONARY STENTING

被引：0
|
作者：
Kim, M. H. [1 ]
Guo, L. Z. [2 ]
Shim, C. H. [2 ]
Choi, S. Y. [2 ]
Serebruany, V. L. [3 ]
机构：
[1] Dong A Univ Hosp, Global Clin Trial Ctr, Cardiol, Busan, South Korea
[2] Dong A Univ Hosp, Busan, South Korea
[3] Johns Hopkins Univ, HeartDrug Res Labs, Baltimore, MD USA
来源：
THROMBOSIS RESEARCH | 2016年 / 141卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C0152
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [31] High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice
    Puchinyan, N. F.
    Furman, N. V.
    Dolotovskaya, P. V.
    Malinova, L. I.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (04) : 385 - 390
  • [32] Evaluation of platelet reactivity on dual antiplatelet therapy in patient with essential thrombocythemia and acute coronary syndrome
    Dineva, D.
    Paskaleva, I.
    Todorieva-Todorova, D.
    CLINICA CHIMICA ACTA, 2019, 493 : S405 - S405
  • [33] Platelet reactivity in patients with coronary artery disease undergoing dual antiplatelet therapy with aspirin and clopidogrel
    Nguyen, My H. T.
    Nguyen, Nghia T.
    BIOMEDICAL RESEARCH AND THERAPY, 2024, 11 (05): : 6426 - 6433
  • [34] DUAL ANTIPLATELET THERAPY FOLLOWING CORONARY ARTERY BYPASS SURGERY: PREDICTORS AND OUTCOMES
    Banerjee, Subhash
    Ahmad, Iqbal
    Master, Ryan
    Weideman, Rick
    Little, Bertis
    Rao, Sunil V.
    Brilakis, Emmanouil S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1921 - E1921
  • [35] Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor
    Nardin, Matteo
    Verdoia, Monica
    Sartori, Chiara
    Pergolini, Patrizia
    Rolla, Roberta
    Barbieri, Lucia
    Schaffer, Alon
    Marino, Paolo
    Bellomo, Giorgio
    Suryapranata, Harry
    De Luca, Giuseppe
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 66 (04) : 364 - 370
  • [36] Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy
    Monica Verdoia
    Patrizia Pergolini
    Roberta Rolla
    Matteo Nardin
    Lucia Barbieri
    Alon Schaffer
    Giorgio Bellomo
    Paolo Marino
    Harry Suryapranata
    Giuseppe De Luca
    Cardiovascular Drugs and Therapy, 2015, 29 : 443 - 450
  • [37] Efficacy and safety of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
    Hwang, Doyeon
    Park, Kyung Woo
    Lee, Joo Myung
    Rhee, Tae-Min
    Hong, Myeong-Ki
    Jang, Yangsoo
    Valgimigli, Marco
    Colombo, Antonio
    Gilard, Martine
    Palmerini, Tullio
    Stone, Gregg W.
    Kim, Hyo-Soo
    AMERICAN HEART JOURNAL, 2018, 197 : 103 - 112
  • [38] Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy
    Verdoia, Monica
    Pergolini, Patrizia
    Rolla, Roberta
    Nardin, Matteo
    Barbieri, Lucia
    Schaffer, Alon
    Bellomo, Giorgio
    Marino, Paolo
    Suryapranata, Harry
    De Luca, Giuseppe
    CARDIOVASCULAR DRUGS AND THERAPY, 2015, 29 (05) : 443 - 450
  • [39] Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor
    Barbieri, Lucia
    Pergolini, Patrizia
    Verdoia, Monica
    Rolla, Roberta
    Nardin, Matteo
    Marino, Paolo
    Bellomo, Giorgio
    Suryapranata, Harry
    De Luca, Giuseppe
    VASCULAR PHARMACOLOGY, 2016, 79 : 11 - 15
  • [40] Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor
    Barbieri, Lucia
    Verdoia, Monica
    Nardin, Matteo
    Marino, Paolo
    Suryapranata, Harry
    De Luca, Giuseppe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B82 - B82
12345